Showing 20 of 102 recruiting trials for “perihilar-cholangiocarcinoma”
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis
DEB-TACE vs cTACE in HCC After TIPS
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
👨⚕️ Salah Al-Batran, Prof. Dr., Frankfurter Institut für Klinische Krebsforschung IKF GmbH📍 8 sites📅 Started Nov 2025View details ↗
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
👨⚕️ Jinbo Yue, Doctor, Shandong Cancer Hospital and Institute📍 1 site📅 Started Jul 2025View details ↗
HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma
RecruitingNCT06986486 ↗
Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
👨⚕️ Tingbo Liang, MD, Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine📍 1 site📅 Started Jun 2025View details ↗
The Dragon PLC Trial (DRAGON-PLC)
A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
A Study of MGC028 in Participants With Advanced Solid Tumors
En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma
Enrolling by InvitationNCT06624189 ↗
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery
Page 1 of 6Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →